Clarissa Desjardins
Director/Miembro de la Junta en BELLUS HEALTH .
Fortuna: 2 M $ al 30/04/2024
Cargos activos de Clarissa Desjardins
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BELLUS HEALTH | Director/Miembro de la Junta | 27/09/2017 | - |
| INSMED INCORPORATED | Director/Miembro de la Junta | 01/11/2019 | - |
| Independent Dir/Board Member | 01/11/2019 | - | |
Congruence Therapeutics, Inc.
 Congruence Therapeutics, Inc. BiotechnologyHealth Technology Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021. | Director Ejecutivo | - | - |
| Fundador | 04/01/2021 | - | |
| Presidente | 04/01/2021 | - | |
| Secretario Corporativo | 04/01/2021 | - | |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Director/Miembro de la Junta | - | - |
Historial de carrera de Clarissa Desjardins
Antiguos cargos conocidos de Clarissa Desjardins.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CLEMENTIA PHARMACEUTICALS INC | Director/Miembro de la Junta | 01/01/2011 | 01/04/2019 |
| Director Ejecutivo | 01/01/2011 | 01/04/2019 | |
| Fundador | 01/01/2011 | 01/04/2019 | |
| Presidente | 01/01/2011 | 01/04/2019 | |
| Cepmed | Director/Miembro de la Junta | 01/01/2009 | 01/01/2012 |
| Director Ejecutivo | 01/01/2009 | 01/01/2012 | |
| Presidente | 01/01/2009 | 01/01/2012 | |
La Fondation de l'innovation du Nouveau-Brunswick
 La Fondation de l'innovation du Nouveau-Brunswick Investment ManagersFinance La Fondation de l'innovation du Nouveau-Brunswick is an Independent Venture Capital firm founded in 2003. La Fondation de l'innovation du Nouveau-Brunswick is headquartered in Fredericton. | Director/Miembro de la Junta | - | 01/11/2008 |
Caprion Pharmaceuticals, Inc.
 Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Caprion Pharmaceuticals, Inc. discovered and developed pharmaceutical products. It offered a proprietary therapeutic pipeline in oncology and infectious diseases. Caprion Pharmaceuticals proteomics discovery technologies used to enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly enhance clinical development productivity and decision making. The company was founded in 1998 and was headquartered in Montreal, Canada. | Director/Miembro de la Junta | 01/01/1998 | 01/01/2007 |
| Fundador | 01/01/1998 | 01/01/2007 | |
| Corporate Officer/Principal | 01/01/1998 | 01/01/2007 | |
Advanced Bioconcept Ltd.
 Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Nen Tm Life Science Products, Inc., Advanced Bioconcept Ltd. is a Canadian company that makes proprietary, fluorescent labeled peptides. The company is based in Montréal, Canada. The company was founded by Clarissa Desjardins. Advanced Bioconcept was acquired by Nen Tm Life Science Products, Inc. on September 25, 1998. | Fundador | 01/05/1992 | 01/01/1998 |
| Corporate Officer/Principal | 01/05/1992 | 01/01/1998 | |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formación de Clarissa Desjardins.
| McGill University | Undergraduate Degree |
Estadísticas
Internacional
| Canadá | 12 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 9 |
| Founder | 4 |
| Chief Executive Officer | 3 |
Sectorial
| Health Technology | 7 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 9 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Caprion Pharmaceuticals, Inc.
Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Caprion Pharmaceuticals, Inc. discovered and developed pharmaceutical products. It offered a proprietary therapeutic pipeline in oncology and infectious diseases. Caprion Pharmaceuticals proteomics discovery technologies used to enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly enhance clinical development productivity and decision making. The company was founded in 1998 and was headquartered in Montreal, Canada. | Health Technology |
Advanced Bioconcept Ltd.
Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Nen Tm Life Science Products, Inc., Advanced Bioconcept Ltd. is a Canadian company that makes proprietary, fluorescent labeled peptides. The company is based in Montréal, Canada. The company was founded by Clarissa Desjardins. Advanced Bioconcept was acquired by Nen Tm Life Science Products, Inc. on September 25, 1998. | Electronic Technology |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Commercial Services |
La Fondation de l'innovation du Nouveau-Brunswick
La Fondation de l'innovation du Nouveau-Brunswick Investment ManagersFinance La Fondation de l'innovation du Nouveau-Brunswick is an Independent Venture Capital firm founded in 2003. La Fondation de l'innovation du Nouveau-Brunswick is headquartered in Fredericton. | Finance |
| Cepmed | |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Commercial Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
Congruence Therapeutics, Inc.
Congruence Therapeutics, Inc. BiotechnologyHealth Technology Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Clarissa Desjardins
- Experiencia
